Acriflavine/guanosine

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAcriflavine/guanosine
Drug Alias NameAG-60
ClassificationSmall molecules
Mechanisms of ActionHypoxia-inducible factor prolyl hydroxylase inhibitorsLysyl oxidase inhibitors
TargetsHypoxia-inducible factor prolyl hydroxylaseLysyl oxidase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Acriflavine
Global Highest StatusDiscontinued (Clinical)
Highest Status in ChinaN/A
Originator CompaniesMedvill
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedvill
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A